Abstract
From the pandemic scenario of COVID-19 disease cases in all over the world, the outbreak prediction becomes very complex for the emerging scientifically research. Several epidemiological mathematical models of spread are increasing day by day to forecast correctly. Here, the classical SIR modelling approach is carried out to study the different parameters of this model in case of India county. This type of approach analyzed by considering different governmental lock down measures in India. There are some assumptions were taken into account for fitting the model in Python simulation in each lock down scenario. The predicted parameters of SIR model showed some improvement in each case of lock down in India. The outcome results showed the extreme interventions should be taken to tackle this type of pandemic situation in near future.
Author approval This article does not contain any studies with human participants or animals performed by any of the authors.
Competing interests The authors declare no competing interests.
Declarations The authors declare that there is no conflict of interest regarding the publication of this article.
Data availability statement The working data set used for this study has been submitted to the journal as additional supporting files.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The trial ID from an internationally recognized trial registry is not required for the mathematical case study of open online data set which are published Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).
Funding Statement
There is no funding for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The authors declare that there is no conflict of interest regarding the publication of this article.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.